Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Prostate Cancer Clinical Trials in Dallas | 283 Studies

Clinical Trials Prostate CancerDallas

Prostate Cancer Clinical Trials in Dallas

Find 283 clinical trials for prostate cancer near Dallas, Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Dallas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 221-240 of 283 trials

TerminatedPositive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate CancerThe primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant…NCT01981109·Anchorage, Alaska and 57 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerThe purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from…NCT01322490·Anchorage, Alaska and 219 others

CompletedRandomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue AdministrationThe purpose of this study is to compare how subjects feel after receiving injections of two different types of GnRH six months apart.NCT01161563·Homewood, Alabama and 15 others

RecruitingTesting the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine CellsThis phase II trial studies how well lutetium Lu 177 dotatate works in treating patients with prostate cancer with neuroendocrine differentiation that has spread to other places…NCT05691465·Duarte, California and 12 others

RecruitingPositron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical ProstatectomyThe aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.NCT06056830·Birmingham, Alabama and 33 others

CompletedA Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate CancerThe purpose of this study is to evaluate the efficacy of TAK 385 for achieving and maintaining testosterone suppression (\<50 ng/dL).NCT02083185·Birmingham, Alabama and 22 others

CompletedA Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate CancerThis study is being done to evaluate the safety and efficacy of atrasentan in men with metastatic hormone-refractory prostate cancer.NCT00036543·Homewood, Alabama and 231 others

CompletedSafety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate CancerThis is a Phase I, non-randomized, dose escalation study of the safety, biomarkers, and preliminary efficacy of dendritic cell vaccine, BPX-201, plus activating agent, AP1903, in…NCT01823978·Birmingham, Alabama and 1 other

Active not recruitingA Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage TumorsThis study is a first-in-human (FIH), Phase 1a/1b study of BG-68501, a cyclin-dependent kinase-2 inhibitor (CDK2i), to assess the safety, tolerability, pharmacokinetics (PK)…NCT06257264·Newport Beach, California and 23 others

RecruitingA Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)Himalayas-1 is a randomized, open-label, global, multicenter phase 3 study evaluating whether the combination of rinzimetostat with darolutamide is more effective compared to…NCT07723248·Jeffersonville, Indiana and 6 others

CompletedStudy to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.The main purpose of this first human study with CC-115 is to assess the safety and action of a new class of experimental drug (dual DNA-PK and TOR kinase inhibitors) in patients…NCT01353625·Los Angeles, California and 16 others

RecruitingStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)This is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant…NCT06136624·Orange, California and 287 others

TerminatedCombo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPCThis study was conducted in subjects in chemotherapy-naïve subjects with bone-metastatic castration-resistant prostate cancer (CRPC).NCT01995058·Scottsdale, Arizona and 19 others

CompletedRadiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells and shrink tumors. Androgens can cause the growth of prostate cancer cells.NCT00936390·Birmingham, Alabama and 517 others

TerminatedA Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPCThe purpose of this study is to compare galeterone to enzalutamide in men expressing androgen receptor spice variant-7 mRNA (AR-V7) in metastatic (M1) castrate resistant prostate…NCT02438007·Scottsdale, Arizona and 116 others

SuspendedRadiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal TherapyThis phase I/II trial studies the best dose of M3814 when given together with radium-223 dichloride or with radium-223 dichloride and avelumab and to see how well they work in…NCT04071236·Duarte, California and 31 others

RecruitingLong-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate CancerThe purpose of this post-marketing study is to further characterize the long-term outcome of known or potential risks of lutetium (177Lu) vipivotide tetraxetan also known as…NCT05803941·Scottsdale, Arizona and 53 others

RecruitingScreening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland.NCT06626022·Los Angeles, California and 8 others

Active not recruitingA Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPCThe purpose of the study is to determine if the intermittent use of androgen-deprivation therapy (ADT) in participants with metastatic castrate-sensitive prostate cancer (mCSPC)…NCT05884398·Homewood, Alabama and 92 others

RecruitingA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsThis is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1311/BNT324 in subjects with advanced solid tumors.NCT05914116·Tucson, Arizona and 106 others

PreviousPage 12 of 15Next

Other Conditions in Dallas

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma